Nicolas Fulpius brings several years of experience in the private equity and venture capital industry. Mainly active with start-up, high growth and hightech companies, he is today CEO of Veltigroup a leading ICT service provider in Switzerland and the acting Chairman of the Board of inflaRx. His prior assignments include multiple Chairman positions (Selfrag, SIRS-Lab, Dunes Technologies). Before affentranger associates, he was investment director at Ultreia Capital, a venture company focusing on biotech and acted as private equity portfolio manager for the LODH Immunology Fund, a fund specializing in the life sciences industry.
Nicolas Fulpius holds a MBA (HSG lic. oec.) from the University of St. Gall (Switzerland) and a MS in Engineering from Stanford University (USA).